By THE ASSOCIATED PRESS
NYT Politics
Consumer and health care groups are scrambling to block what they say is a move by the pharmaceutical industry to commandeer must-pass opioids epidemic legislation as a vehicle for rolling back drugmaker discounts to Medicare beneficiaries with hi...
Published date: September 21, 2018 at 09:35PM
AP
New York Times article
Няма коментари:
Публикуване на коментар